Morgan Stanley’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.21M | Buy |
3,557,048
+62,919
| +2% | +$163K | ﹤0.01% | 3515 |
|
|
2025
Q1 | $23.5M | Buy |
3,494,129
+421,291
| +14% | +$2.84M | ﹤0.01% | 2531 |
|
|
2024
Q4 | $20.9M | Sell |
3,072,838
-716,107
| -19% | -$4.86M | ﹤0.01% | 2704 |
|
|
2024
Q3 | $31.4M | Buy |
3,788,945
+317,868
| +9% | +$2.64M | ﹤0.01% | 2318 |
|
|
2024
Q2 | $22M | Buy |
3,471,077
+819,632
| +31% | +$5.2M | ﹤0.01% | 2557 |
|
|
2024
Q1 | $24.6M | Sell |
2,651,445
-1,905,997
| -42% | -$17.7M | ﹤0.01% | 2473 |
|
|
2023
Q4 | $58.1M | Buy |
4,557,442
+2,337,616
| +105% | +$29.8M | ﹤0.01% | 2282 |
|
|
2023
Q3 | $22.9M | Buy |
2,219,826
+246,302
| +12% | +$2.54M | ﹤0.01% | 2309 |
|
|
2023
Q2 | $25.9M | Sell |
1,973,524
-640,847
| -25% | -$8.4M | ﹤0.01% | 2207 |
|
|
2023
Q1 | $29.2M | Buy |
2,614,371
+463,866
| +22% | +$5.19M | ﹤0.01% | 2035 |
|
|
2022
Q4 | $18.1M | Buy |
2,150,505
+296,682
| +16% | +$2.5M | ﹤0.01% | 2441 |
|
|
2022
Q3 | $30.9M | Sell |
1,853,823
-273,948
| -13% | -$4.56M | ﹤0.01% | 1743 |
|
|
2022
Q2 | $31.3M | Buy |
2,127,771
+1,897,698
| +825% | +$27.9M | ﹤0.01% | 1796 |
|
|
2022
Q1 | $5.71M | Buy |
230,073
+163,024
| +243% | +$4.05M | ﹤0.01% | 3545 |
|
|
2021
Q4 | $2.15M | Buy |
67,049
+48,171
| +255% | +$1.55M | ﹤0.01% | 4527 |
|
|
2021
Q3 | $680K | Sell |
18,878
-46,158
| -71% | -$1.66M | ﹤0.01% | 5311 |
|
|
2021
Q2 | $2.87M | Buy |
65,036
+20,533
| +46% | +$906K | ﹤0.01% | 4325 |
|
|
2021
Q1 | $2.04M | Buy |
44,503
+30,316
| +214% | +$1.39M | ﹤0.01% | 4246 |
|
|
2020
Q4 | $979K | Buy |
+14,187
| New | +$979K | ﹤0.01% | 4684 |
|